Melagatran 产品说明书 Chemicals
导航 首页 > 产品 > Featured products
产品编号 DC26032
名称 Melagatran

化学性质

CAS 159776-70-2
分子式 C22H31N5O4
分子量 429.5
存储条件 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

生物活性

Description
In Vivo
In Vitro

化合物的使用

Kinase Assay
Cell Assay
Animal Administration

参考文献


Melagatran has rapid onset of action, fixed twice-daily dosing, stable absorption, apparent low potential for medication interactions, and no requirement for monitoring drug levels or dose adjustment. There is no specific antidote, but the drug has a short plasma elimination half-life (about 4 hours). In clinical studies, melagatran/ximelagatran is not inferior to warfarin for stroke prevention in patients with non-valvular atrial fibrillation, to heparin-warfarin for acute treatment and extended secondary prevention of deep vein thrombosis, and superior to warfarin for prevention of venous thromboembolism after major orthopaedic surgery. Major bleeding with melagatran/ximelagatran occurred at rates similar to those in patients treated with warfarin. 6%-12% of patients taking ximelagatran develop asymptomatic elevated liver enzyme levels (predominantly alanine aminotransferase) after 1-6 months of therapy; this usually resolves with cessation of therapy. Less than 1% of patients develop abnormal liver function while taking ximelagatran; this rarely persists or develops into clinical illness.
退货政策
如果您对于您的订单不满意,您可以在购买日365天内将产品退回。
下订单的时候请提供您的快递地址以及开票信息
电话: +86-21-58447131
传真: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

网址:
http://www.dcbio.cn/